• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

BDP Baltimore South

Anonymous

Guest
can anyone shed some light on this opening? Why this position is available and if it is a good territory. Please only serious responses as I would like to get into buy and bill, but don't know if the recent changes make this a good decision....thanks